Vaccines & Related Biological Products
Executive Summary
A discussion of cell substrates used to produce vaccines has been added to the agenda of the FDA advisory committee's Nov. 19 meeting. The meeting will be open from 8 a.m. to 1:30 p.m., after which the committee will meet in closed session to discuss trade secret or confidential information. On Nov. 20, the committee is set to discuss the manufacture of influenza vaccines ("The Pink Sheet" Oct. 19, In Brief). The meeting is to be held at the Holiday Inn in Bethesda, Md